Institutional investors purchased a net $17.2 million shares of TEVA during the quarter ended September 2014, and now own 53.71% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WADDELL & REED INVESTMENT MANAGE... Bought 7.1 Million shares of Teva Pharmaceutical
ROBECO INVESTMENT MANAGEMENT, IN... Bought 4.9 Million shares of Teva Pharmaceutical
WILLIAM BLAIR & CO. LLC (INVESTM... Bought 4.6 Million shares of Teva Pharmaceutical